Suchergebnisse - "Horrigan, Stephen"

PubPharm (57)

1

Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression

enthalten in: Leukemia | 2024

von Birdwell, C. | Fiskus, W. | Kadia, T. | +15

2

Replication-driven HBV cccDNA loss in chimeric mice with humanized livers

enthalten in: bioRxiv.org | 2023

von Zhang, B. | Zhou, Y. | Tempel, B. | +6

3

Replication-driven HBV cccDNA loss in chimeric mice with humanized livers

enthalten in: bioRxiv : the preprint server for biology | 2023

von Zhang, B. | Zhou, Y. | Tempel, B. | +6

4

Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model

enthalten in: Viruses | 2022

von Stoddart, C. | Curreli, F. | Horrigan, S. | +3

5

FORMULATIONS OF TEGAVIVINT AND RELATED COMPOUNDS

enthalten in: Europäisches Patentamt | 2022

von DYKSTRA STEVEN DAVID | HAVEL HENRY | HORRIGAN STEPHEN | +5

6

Methods for treatment of fibrotic diseases

enthalten in: Europäisches Patentamt | 2022

von HAN RUOLAN | NORTHRUP JON | KASIBHATLA SRINIVAS | +2

7

FORMULATIONS OF TEGAVIVINT AND RELATED COMPOUNDS

enthalten in: Europäisches Patentamt | 2022

von DYKSTRA STEVEN DAVID | HAVEL HENRY | HORRIGAN STEPHEN | +5

8

FORMULATIONS OF TEGAVIVINT AND RELATED COMPOUNDS

enthalten in: Europäisches Patentamt | 2022

von DYKSTRA STEVEN DAVID | HAVEL HENRY | HORRIGAN STEPHEN | +5

9

Formulations of tegavivint and related compounds

enthalten in: Europäisches Patentamt | 2022

von DYKSTRA STEVEN DAVID | HAVEL HENRY | HORRIGAN STEPHEN | +5

10

METHODS OF INHIBITING LYSINE-SPECIFIC DEMETHYLASE 1 (LSD-1)

enthalten in: Europäisches Patentamt | 2022

von BLUMBERG SHAWN | BOHMANN JONATHAN | DUNCAN AUNDRIETTA D | +3

1
2
3
4
5
6
Nächster »
[6]